A BUDGET IMPACT MODEL (BIM) FOR THE INTRODUCTION OF THE TEARCARE® SYSTEM TO A UNITED STATES (US) HEALTH PLAN FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION (MGD)-ASSOCIATED DRY EYE DISEASE (DED)

被引：0
|
作者：
Masseria, C. [1 ]
Chester, T. [2 ]
Longo, R. [1 ]
Riley, P. [3 ]
Patel, C. [1 ]
Mody, L. [1 ]
机构：
[1] AESARA Inc, Chapel Hill, NC USA
[2] Cleveland Eye Clin, Bedford, OH USA
[3] AESARA Inc, Wilson, NC USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE438
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 11 条
  • [1] Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED) in the United States (US)
    Chester, Thomas
    Longo, Roberta
    Masseria, Cristina
    Riley, Phoenix
    Patel, Chad
    Mody, Lorie
    EXPERT REVIEW OF OPHTHALMOLOGY, 2025, 20 (01) : 55 - 61
  • [2] Effectiveness of TearCare System in Improvement Dry Eye Disease Symptoms in Meibomian Gland Dysfunction
    Bloomenstein, Marc
    Loh, Jennifer
    Dhamdhere, Kavita
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [3] QUALITATIVE RESEARCH TO UNDERSTAND THE LIVED EXPERIENCE OF PATIENTS WITH DRY EYE DISEASE (DED), MEIBOMIAN GLAND DYSFUNCTION (MGD), AND SJOGREN'S SYNDROME DRY EYE DISEASE (SS-DED)
    Sloesen, B.
    Young, A.
    Tinsley, K.
    Sharp, R.
    Walsh, O.
    Naujoks, C.
    Sharma, G.
    O'Brien, P.
    Bentley, S.
    VALUE IN HEALTH, 2022, 25 (12) : S407 - S408
  • [4] TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
    Gupta, Preeya K.
    Holland, Edward J.
    Hovanesian, John
    Loh, Jennifer
    Jackson, Mitchell A.
    Karpecki, Paul M.
    Dhamdhere, Kavita
    CORNEA, 2022, 41 (04) : 417 - 426
  • [5] Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)-related dry eye disease (DED): a systematic review and meta-analysis
    Lei, Yahui
    Peng, Jing
    Liu, Jiayan
    Zhong, Jingxiang
    LASERS IN MEDICAL SCIENCE, 2022, 38 (01)
  • [6] Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)–related dry eye disease (DED): a systematic review and meta-analysis
    Yahui Lei
    Jing Peng
    Jiayan Liu
    Jingxiang Zhong
    Lasers in Medical Science, 38
  • [7] CONTENT VALIDITY ASSESSMENT OF A NEWLY-DEVELOPED PATIENT-REPORTED OUTCOME MEASURE FOR DRY EYE DISEASE (DED), MEIBOMIAN GLAND DYSFUNCTION (MGD), AND SJOGREN'S SYNDROME DRY EYE DISEASE (SS-DED)
    Sloesen, B.
    Young, A.
    Hodson, N.
    Smith, V
    Walsh, O.
    Naujoks, C.
    Sharma, G.
    O'Brien, P.
    Arbuckle, R.
    VALUE IN HEALTH, 2022, 25 (12) : S394 - S395
  • [8] Long-term safety and efficacy of NOV03 (perfluorohexyloctane) for the treatment of patients with dry eye disease associated with meibomian gland dysfunction: the KALAHARI study
    Vittitow, Jason
    Protzko, Eugene
    Segal, Bruce
    Korenfeld, Michael
    Kroesser, Sonja
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] BUDGET IMPACT OF ELBASVIR/GRAZOPREVIR (EBR/GZR) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPES 1 AND 4 IN A UNITED STATES (US) HEALTH PLAN
    Corman, S. L.
    Nwankwo, C.
    Jiang, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A73 - A73
  • [10] Daily Warm Compress Therapy Augmented with Manual Lid Expressions vs a Single Thermal Pulsation System Treatment for Evaporative Dry Eye Disease Secondary to Meibomian Gland Dysfunction
    McPherson, Andrew T.
    Wu, Rina
    Oliver, Paula
    Pullen, Jerome A.
    Greiner, Jack V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12